(Reuters) – The government of Australia has signed an advanced agreement to purchase 51 million doses of Novavax Inc’s experimental COVID-19 vaccine, the company disclosed in a regulatory filing on Thursday. (https://bit.ly/35BGW3Z)
(Reporting by Trisha Roy in Bengaluru; Editing by Shounak Dasgupta)
